MedTrace Logo

Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)

NCT03230201 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-08-08

No results posted yet for this study

Summary

This clinical trial is designed to evaluate the role of lymph node dissection in the prevention of recurrence and metastasis after radical nephroureterectomy for high-risk primary upper tract urothelial carcinoma (UTUC) patients.

Conditions

  • Recurrence
  • Metastasis
  • Upper Tract Urothelial Carcinoma
  • Lymph Node Dissection

Interventions

PROCEDURE

Lymph node dissection

Lymph node dissection during radical nephroureterectomy

Sponsors & Collaborators

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Liqun Zhou, M.D. · Peking University First Hosipital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03230201 on ClinicalTrials.gov